晚期发生的伦诺克斯-加斯托综合征
1University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642.
Seminars in pediatric neurology
|December 10, 2025
概括
晚期发病的伦诺斯-加斯托综合征 (LGS),定义为8岁后开始的LGS,可能呈现出正常发育和可能比早期发病形式更好的认知结果. 需要进一步的研究才能充分理解这种罕见的疾病.
科学领域:
- 神经学 神经学
- 儿科神经学 儿科神经学
- 罕见疾病 罕见疾病
背景情况:
- 晚期发病的伦诺斯-加斯托综合征 (LGS) 被定义为8岁后发病的LGS.
- 它的典型发作发生在18个月到8岁之间.
- 人们对这种罕见的晚发病形式知之甚少.
研究的目的:
- 审查有关晚发LGS的现有英语文献.
- 阐明当前关于临床表现,病因,并发症和结果的知识.
- 为了确定这个患者群体的未来研究需求.
主要方法:
- 英语出版物的文献综述.
- 报告的临床特征,病因和结果的分析.
- 确定现有研究的局限性.
主要成果:
- 晚期LGS可能具有较高比例的患者,最初的发育和认知正常.
- 较少的晚发LGS患者有先前的婴儿.
- 与早期LGS相比,认知结果可能更有利.
结论:
- 目前对晚发LGS的研究受限于年龄的变化标准,图像和遗传数据不足,样本规模小.
- 有必要进行一项大规模的研究,采用统一的诊断标准,详细的人口统计,现代成像,遗传检测和长期跟踪.
- 进一步的研究是必不可少的,以准确地描述晚发LGS.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
857
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
857
Long-term Depression
33.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K
Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Long-term Potentiation
58.1K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
58.1K
Long-term Potentiation
3.4K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
3.4K


